OpenURL Connection Search

Select item for more details and to access through your institution.

FIVE‐YEAR FOLLOW‐UP OF FIRST‐LINE IBRUTINIB FOR TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA//SMALL LYMPHOCYTIC LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 103, doi. 10.1002/hon.67_2629
By:
- Tedeschi, A.;
- Burger, J.;
- Barr, P.M.;
- Robak, T.;
- Owen, C.;
- Ghia, P.;
- Bairey, O.;
- Hillmen, P.;
- Coutre, S.;
- Devereux, S.;
- Grosicki, S.;
- McCarthy, H.;
- Li, J.;
- Simpson, D.;
- Offner, F.;
- Moreno, C.;
- Dai, S.;
- Lal, I.;
- Dean, J.P.;
- Kipps, T.J.
Publication type:
Article
A PHASE 2 STUDY TO ASSESS THE SAFETY AND EFFICACY OF UMBRALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) WHO ARE INTOLERANT TO PRIOR BTK OR PI3K DELTA INHIBITOR THERAPY.
Published in:
Hematological Oncology, 2019, v. 37, p. 88, doi. 10.1002/hon.56_2629
By:
- Mato, A.R.;
- Schuster, S.J.;
- Lamanna, N.;
- Pagel, J.M.;
- Flinn, I.W.;
- Barrientos, J.;
- Reeves, J.A.;
- Cheson, B.D.;
- Barr, P.M.;
- Kambhampati, S.;
- Lansigan, F.;
- Pu, J.J.;
- Skarbnik, A.;
- Fonseca, G.;
- Dorsey, C.;
- LaRatta, N.M.;
- Weissbrot, H.;
- Svoboda, J.;
- Luning Prak, E.T.;
- Tsao, P.
Publication type:
Article
NIVOLUMAB COMBINED WITH BRENTUXIMAB VEDOTIN FOR RELAPSED/REFRACTORY PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA: EFFICACY AND SAFETY FROM THE PHASE 2 CHECKMATE 436 STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 157, doi. 10.1002/hon.114_2629
By:
- Zinzani, P.L.;
- Santoro, A.;
- Gritti, G.;
- Brice, P.;
- Barr, P.M.;
- Kuruvilla, J.;
- Cunningham, D.;
- Kline, J.;
- Johnson, N.A.;
- Mehta‐Shah, N.A.;
- Manley, T.;
- Francis, S.;
- Sharma, M.;
- Moskowitz, A.J.
Publication type:
Article
FIVE‐YEAR FOLLOW‐UP OF FIRST‐LINE IBRUTINIB FOR TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA//SMALL LYMPHOCYTIC LYMPHOMA.
Published in:
Hematological Oncology, 2019, v. 37, p. 103, doi. 10.1002/hon.67_2629
By:
- Tedeschi, A.;
- Burger, J.;
- Barr, P.M.;
- Robak, T.;
- Owen, C.;
- Ghia, P.;
- Bairey, O.;
- Hillmen, P.;
- Coutre, S.;
- Devereux, S.;
- Grosicki, S.;
- McCarthy, H.;
- Li, J.;
- Simpson, D.;
- Offner, F.;
- Moreno, C.;
- Dai, S.;
- Lal, I.;
- Dean, J.P.;
- Kipps, T.J.
Publication type:
Article
A PHASE 2 STUDY TO ASSESS THE SAFETY AND EFFICACY OF UMBRALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) WHO ARE INTOLERANT TO PRIOR BTK OR PI3K DELTA INHIBITOR THERAPY.
Published in:
Hematological Oncology, 2019, v. 37, p. 88, doi. 10.1002/hon.56_2629
By:
- Mato, A.R.;
- Schuster, S.J.;
- Lamanna, N.;
- Pagel, J.M.;
- Flinn, I.W.;
- Barrientos, J.;
- Reeves, J.A.;
- Cheson, B.D.;
- Barr, P.M.;
- Kambhampati, S.;
- Lansigan, F.;
- Pu, J.J.;
- Skarbnik, A.;
- Fonseca, G.;
- Dorsey, C.;
- LaRatta, N.M.;
- Weissbrot, H.;
- Svoboda, J.;
- Luning Prak, E.T.;
- Tsao, P.
Publication type:
Article
NIVOLUMAB COMBINED WITH BRENTUXIMAB VEDOTIN FOR RELAPSED/REFRACTORY PRIMARY MEDIASTINAL LARGE B‐CELL LYMPHOMA: EFFICACY AND SAFETY FROM THE PHASE 2 CHECKMATE 436 STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 157, doi. 10.1002/hon.114_2629
By:
- Zinzani, P.L.;
- Santoro, A.;
- Gritti, G.;
- Brice, P.;
- Barr, P.M.;
- Kuruvilla, J.;
- Cunningham, D.;
- Kline, J.;
- Johnson, N.A.;
- Mehta‐Shah, N.A.;
- Manley, T.;
- Francis, S.;
- Sharma, M.;
- Moskowitz, A.J.
Publication type:
Article
A PILOT STUDY OF BRENTUXIMAB VEDOTIN AND AVD CHEMOTHERAPY FOLLOWED BY 20 GY INVOLVED-SITE RADIOTHERAPY IN EARLY STAGE, UNFAVORABLE RISK HODGKIN LYMPHOMA.
Published in:
Hematological Oncology, 2017, v. 35, p. 171, doi. 10.1002/hon.2438_30
By:
- Kumar, A.;
- Casulo, C.;
- Advani, R.;
- Budde, E.;
- Barr, P.M.;
- Batlevi, C.L.;
- Chen, R.;
- Constine, L.S.;
- Courtien, A.I.;
- Dandapani, S.V.;
- Drullinsky, P.;
- Friedberg, J.W.;
- Hamlin, P.A.;
- Hoppe, R.T.;
- Matasar, M.J.;
- McArthur, G.N.;
- Miller, S.T.;
- Moskowitz, A.J.;
- Noy, A.;
- Schoder, H.
Publication type:
Article
INTEGRATED ANALYSIS: OUTCOMES OF IBRUTINIB-TREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LEUKEMIA (CLL/SLL) WITH HIGH-RISK PROGNOSTIC FACTORS.
Published in:
Hematological Oncology, 2017, v. 35, p. 109, doi. 10.1002/hon.2437_99
By:
- Kipps, T.J.;
- Fraser, G.;
- Coutre, S.E.;
- Brown, J.R.;
- Barrientos, J.C.;
- Barr, P.M.;
- Byrd, J.C.;
- O'Brien, S.M.;
- Dilhuydy, M.;
- Hillmen, P.;
- Jaeger, U.;
- Moreno, C.;
- Cramer, P.;
- Stilgenbauer, S.;
- Chanan ‐ Khan, A.A.;
- Mahler, M.;
- Salman, M.;
- Cheng, M.;
- Londhe, A.;
- Ninomoto, J.
Publication type:
Article
THE 23-GENE GENE EXPRESSION-BASED ASSAY DOES NOT PREDICT INTERIM PET SCAN RESULTS AFTER ABVD IN ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA IN THE US INTERGROUP S0816 TRIAL.
Published in:
Hematological Oncology, 2017, v. 35, p. 92, doi. 10.1002/hon.2437_81
By:
- Scott, D.W.;
- Li, H.;
- Harvey, Y.;
- Chan, F.;
- Mottok, A.;
- Boyle, M.;
- Evens, A.M.;
- Schoder, H.;
- Straus, D.J.;
- Bartlett, N.L.;
- Sweetenham, J.W.;
- Barr, P.M.;
- Fanale, M.A.;
- Hsi, E.D.;
- Cook, J.R.;
- Kahl, B.S.;
- Leonard, J.P.;
- Friedberg, J.W.;
- Leblanc, M.;
- Steidl, C.
Publication type:
Article
HIGH-RISK PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA ARE NOT ENROLLED ON CLINICAL TRIALS.
Published in:
Hematological Oncology, 2017, v. 35, p. 181, doi. 10.1002/hon.2438_42
By:
- Reagan, P.;
- Loh, K.P.;
- Baran, A.;
- Hu, J.;
- Casulo, C.;
- Barr, P.M.;
- Friedberg, J.W.
Publication type:
Article
EFFECT OF SINGLE-AGENT IBRUTINIB ON TUMOR DEBULKING AND REDUCTIONS IN TUMOR LYSIS SYNDROME (TLS) RISK IN PATIENTS (PTS) WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL).
Published in:
Hematological Oncology, 2017, v. 35, p. 233, doi. 10.1002/hon.2438_96
By:
- Tam, C.S.;
- Byrd, J.C.;
- O'Brien, S.;
- Coutre, S.;
- Barr, P.M.;
- Furman, R.R.;
- Kipps, T.J.;
- Burger, J.A.;
- Stevens, D.;
- Sharman, J.;
- Ghia, P.;
- Flinn, I.;
- Zhou, C.;
- Ninomoto, J.;
- James, D.F.;
- Wierda, W.G.
Publication type:
Article
LONG-TERM EFFICACY AND SAFETY IN THE RESONATE STUDY: IBRUTINIB IN PATIENTS WITH PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) WITH UP TO FOUR YEARS FOLLOW-UP.
Published in:
Hematological Oncology, 2017, v. 35, p. 235, doi. 10.1002/hon.2438_98
By:
- Montillo, M.;
- Byrd, J.C.;
- Hillmen, P.;
- O'Brien, S.;
- Barrientos, J.C.;
- Reddy, N.M.;
- Coutre, S.;
- Tam, C.S.;
- Mulligan, S.P.;
- Jaeger, U.;
- Barr, P.M.;
- Furman, R.R.;
- Kipps, T.J.;
- Thornton, P.;
- Moreno, C.;
- Pagel, J.M.;
- Burger, J.A.;
- Jones, J.;
- Dai, S.;
- Vezan, R.
Publication type:
Article

Found: 12